A detailed history of Aigen Investment Management, LP transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Aigen Investment Management, LP holds 3,077 shares of INSP stock, worth $584,599. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,077
Holding current value
$584,599
% of portfolio
0.13%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$125.79 - $216.71 $387,055 - $666,816
3,077 New
3,077 $649,000
Q4 2023

Feb 09, 2024

SELL
$125.26 - $203.83 $1.39 Million - $2.26 Million
-11,071 Reduced 78.0%
3,122 $635,000
Q3 2023

Nov 13, 2023

BUY
$185.0 - $326.08 $2.42 Million - $4.26 Million
13,073 Added 1167.23%
14,193 $2.82 Million
Q2 2023

Aug 14, 2023

SELL
$226.52 - $324.64 $359,940 - $515,852
-1,589 Reduced 58.66%
1,120 $363,000
Q1 2023

May 15, 2023

BUY
$229.06 - $278.01 $401,542 - $487,351
1,753 Added 183.37%
2,709 $634,000
Q4 2022

Feb 10, 2023

BUY
$164.02 - $259.76 $156,803 - $248,330
956 New
956 $240,000
Q2 2021

Aug 10, 2021

SELL
$164.93 - $242.23 $608,261 - $893,344
-3,688 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$182.45 - $249.25 $41,781 - $57,078
229 Added 6.62%
3,688 $763,000
Q4 2020

Feb 12, 2021

SELL
$119.35 - $200.46 $870,777 - $1.46 Million
-7,296 Reduced 67.84%
3,459 $651,000
Q3 2020

Nov 06, 2020

SELL
$87.5 - $130.91 $330,050 - $493,792
-3,772 Reduced 25.97%
10,755 $1.39 Million
Q2 2020

Aug 10, 2020

BUY
$49.5 - $97.93 $581,724 - $1.15 Million
11,752 Added 423.5%
14,527 $1.26 Million
Q1 2020

May 08, 2020

SELL
$41.62 - $89.92 $61,722 - $133,351
-1,483 Reduced 34.83%
2,775 $167,000
Q4 2019

Feb 04, 2020

BUY
$52.12 - $75.0 $221,926 - $319,350
4,258 New
4,258 $316,000

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.47B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.